Pharmaceutical Market Access and Drug Safety Act of 2005
Reimportation_Backgrounder_May05.pdf | 83.0 kB
May 9, 2005
This bill would allow reimportation of prescription drugs from Canada within nine months of enactment, and from 19 major industrialized nations that have drug approval and distribution systems similar to ours within a year (the European Union countries and Australia, New Zealand, Japan and Switzerland). Safety of prescription drugs is as critical to consumers as is price. This legislation will increase the FDA’s authority to inspect for safety and ensure compliance, while decriminalizing efforts by Americans to access more affordable prescription drugs. The danger to consumers from drugs reimported from countries with similar systems as ours is minimal, and allowing in only those drugs from FDA-inspected facilities will increase consumer confidence.